Maria Karasarides earned a Ph.D. in biology in 2000. A renowned scientist, she is the executive director of ImmunoOncology Development at Regeneron Pharmaceuticals Inc., a science and technology company delivering life-transforming medicines for serious diseases.
Founded by physician-scientists, the firm’s science-driven approach has resulted in six FDA-approved medicines and numerous product candidates for asthma, pain, cancer, infectious diseases and more.
Dr. Karasarides’ career also includes high-level positions with AstraZeneca, ZIOPHARM, Merrimack, Infinity and Bristol-Myers Squibb. She lives in New York City.